Aprogen Medicines Inc.
Aprogen Medicines Inc. (KRX: 007460) is trading at ₩2,075.00, about ₹150 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 3.94% today. Aprogen Medicines is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩2,070.00
Today's high
₩2,205.00
52 week low
₩1,875.00
52 week high
₩14,062.97
007460 opened at ₩2,160.00, closed previously at ₩2,160.00, and has traded between ₩1,875.00 and ₩14,062.97 over the past 52 weeks.
About
Founded in 1971 and headquartered in Seongnam-si, South Korea, Aprogen Medicines Inc. (formerly Aprogen KIC Inc. until its name change in April 2021) specializes in the design, manufacture, and maintenance of plant facilities. Their services cater to crucial sectors including steelwork, petrochemistry, shipbuilding, power generation, and liquefied natural gas (LNG) base industries. The company also provides thermal and cold spray services, a diverse range of clad products such as rolls, plates, wear plates, pipes, and fittings, along with plasma transferred arcs. Furthermore, Aprogen Medicines Inc. offers the Nukon system, a specialized heat-preservation solution vital for ensuring the safe operation of internal piping within pressurized water reactor power plant containment buildings. They are also a supplier of Foamglas, a cellular glass insulation product, and undertake fireproof insulation works for furnaces and boilers, notably at POSCO.
Key statistics
Avg. volume
280.43K
Market cap
₩2.91B
P/E Ratio
-0.07
Price-to-sales ratio
0.02
Enterprise value
₩372.19B
Free cash flow yield
-18.63%
Debt-to-equity ratio
3.00
Return on equity
-44.34%
ROIC
-20.73%
Beta
0.09
Dividend yield
0.00%
Last dividend
₩0.00
Financial overview
Revenue
₩117.97B
Earnings per share
-₩52,533.75
Free cash flow
-₩42.75B
Net profit margin
-59.62%
Gross margin
20.28%
EBITDA
-₩113.95B
Revenue growth
-21.41%
Similar securities
This is not an investment recommendation
Aprogen Medicines for Indian investors
Aprogen Medicines is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Aprogen Medicines for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneAprogen Medicines does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
FAQs
Can I buy Aprogen Medicines on Paasa?
Aprogen Medicines (007460) has been listed on the Korea Exchange since 2005, in the Conglomerates industry. Aprogen Medicines is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Aprogen Medicines share cost in rupees?
One Aprogen Medicines share is ₩2,075.00 — about ₹150 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Aprogen Medicines price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Aprogen Medicines shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Aprogen Medicines price.
Does Aprogen Medicines pay a dividend?
No. Aprogen Medicines does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one: dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Aprogen Medicines shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Aprogen Medicines?
Yes. Aprogen Medicines is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.